OneSource Reports Strong Q2FY27 Growth Driven by DDC Capacity and Commercial Launches
Onesource Specialty Pharma Ltd · Press Release · 27 Oct 2026, 4:16 pm
OneSource Reports Strong Q2FY27 Growth Driven by DDC Capacity and Commercial Launches OneSource Specialty Pharma reported Q2FY27 revenue of ₹5,162m, up 37% YoY and 15% QoQ, driven by new Drug-Device Combination (DDC) capacity, robust MSA execution, and 12 product launches. EBITDA surged 53% YoY and 32% QoQ to ₹1,633m, with margins expanding 329 bps YoY to 31.6% via operating leverage. Adjusted PAT rose 109% YoY to ₹937m, delivering an adjusted EPS of ₹8.2. Operational momentum included commercializing a second cartridge line and onboarding a US biologics partner. Management reaffirmed its FY28 outlook of $400m organic revenue with 40% steady-state EBITDA margins.
Original exchange filing (PDF)
More announcements from Onesource Specialty Pharma Ltd
- Intimation of resignation of Senior Management Personnel · 17 Nov 2026
- Onesource Specialty Pharma Limited has informed the Exchange about the Participation in Jefferies Global Healthcare Conference to be held from November 16, 2026 to November 19, 2026 in London. · 05 Nov 2026
- Intimation of Transcript of Earnings call dated October 27, 2026 · 03 Nov 2026
- OneSource receives USFDA EIR with VAI Classification, Marking completion of Inspection process at its Sterile Product Division (SPD) Facility in Bengaluru. · 30 Oct 2026
- Intimation of the Audio recording of the earnings call pertaining to the unaudited financial results for the quarter and half year ended September 30, 2026 · 28 Oct 2026
- Intimation of allotment of 360 equity shares of Re.1/- each under ONESOURCE ESOP 2021 on October 27, 2026. · 27 Oct 2026
- Intimation of change in designation of Dr. Claudio Albrecht from Independent director to Non-Executive Non-Independent Director of the Company. · 27 Oct 2026
- Onesource Specialty Pharma Limited has submitted to the Exchange, the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. · 27 Oct 2026
